Massachusetts Medical Society: Massachusetts Medical Society announces policies on crisis pregnancy centers, medical leave, and resilience of the health care medical supply chain

Massachusetts Medical Society announces policies on crisis pregnancy centers, medical leave, and resilience of the health care medical supply chain

WALTHAM – Policies focusing on protecting patients from misleading practices in reproductive health care, medical leave for birthing people, and fertility services for MassHealth enrollees are among those newly adopted by the physician-members of the Massachusetts Medical Society (MMS), a statewide professional association composed of some 25,000 physicians and medical students dedicated to educating and advocating for patients and physicians.

Physicians and medical students from across the state attended the organization’s 2024 Interim Meeting and considered and debated resolutions proposed by MMS members to its House of Delegates, the Medical Society’s governing body. Resolutions that the House of Delegates adopted are now organizational policy.

Below are summaries of some of the Society’s new policies:

Protecting Patients from Misleading and Harmful Practices in Reproductive Health Care

The MMS supports transparency and full disclosure regarding the scope of services offered at all reproductive health care facilities and crisis pregnancy centers. The MMS opposes deceptive practices, including the deliberate use of misleading information, emotional manipulation, and delay tactics that divert patients from accessing comprehensive reproductive health services from licensed medical professionals.

Ensuring Adequate Medical Leave for all Birthing People

The MMS supports a minimum of 12 weeks of medical leave after childbirth, regardless of mode of delivery or other factors, given its demonstrated benefits for bonding, postpartum mental health, and breastfeeding success, consistent with international standards.

Fertility Services for MassHealth Enrollees

The MMS supports expanding MassHealth coverage to include infertility diagnostics and treatments to address disparities and access to care.

Reducing Burden on Physicians Treating Patients Already on Methadone Therapy

The MMS partner with relevant stakeholders to advocate for legislative and regulatory changes that reduce barriers for patients, physicians, and other providers caring for patients currently receiving methadone treatment, by making dosing information more easily and immediately available.

Building Resilience of the Health Care Medical Supply Chain

The MMS supports state policy aimed at building the resilience of the medical supply chain. The MMS will collaborate with the American Medical Association and other stakeholders to support federal efforts aimed at building the resilience of the medical supply chain.

MMS members can view all new policies and final House votes by clicking here.

Share on Facebook
Facebook logoLinkedInYouTube logoInstagramThreads

Copyright © 2024. Massachusetts Medical Society, 860 Winter Street, Waltham Woods Corporate Center, Waltham, MA 02451-1411

(781) 893-4610 | General Support: (617) 841-2925 or support@mms.org